SCHEMBL5349667

SCHEMBL5349667

O=C(O)[C@H]1C[C@H](C(=O)O)C1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C19 P33261 3/20 0.50
▸ GABRR1 P24046 1/20 0.50
▸ CYP2D6 P10635 3/20 0.46
▸ CYP1A2 P05177 3/20 0.46
▸ ALOX15 P16050 3/20 0.46
▸ SLC1A3 P43003 1/20 0.46
▸ SLC1A2 P43004 1/20 0.46
▸ SLC1A1 P43005 1/20 0.46
▸ TSHR P16473 2/20 0.45
▸ PMP22 Q01453 2/20 0.45
▸ APLNR P35414 1/20 0.45
▸ GABRP O00591 1/20 0.45
▸ GABRD O14764 1/20 0.45
▸ GABRA1 P14867 1/20 0.45
▸ GABRB1 P18505 1/20 0.45
▸ GABRG2 P18507 1/20 0.45
▸ GABRB3 P28472 1/20 0.45
▸ GABRA5 P31644 1/20 0.45
▸ GABRA3 P34903 1/20 0.45
▸ GABRA2 P47869 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2038877 1.00 CYP2C19 (0.50) CYP2C19GABRR1CYP2D6CYP1A2ALOX15
SCHEMBL6542917 1.00 CYP2C19 (0.50) CYP2C19GABRR1CYP2D6CYP1A2ALOX15
SCHEMBL326061 1.00 CYP2C19 (0.50) CYP2C19GABRR1CYP2D6CYP1A2ALOX15
SCHEMBL375124 1.00 CYP2C19 (0.50) CYP2C19GABRR1CYP2D6CYP1A2ALOX15
SCHEMBL19902117 1.00 CYP2C19 (0.50) CYP2C19GABRR1CYP2D6CYP1A2ALOX15
SCHEMBL23366184 1.00 CYP2C19 (0.50) CYP2C19GABRR1CYP2D6CYP1A2ALOX15
SCHEMBL8204743 1.00 CYP2C19 (0.50) CYP2C19GABRR1CYP2D6CYP1A2ALOX15
Hydrochloric Acid SCHEMBL4380992 0.96 CYP2C19 (0.47) CYP2C19GABRR1CYP2D6CYP1A2ALOX15
Bromide SCHEMBL29077840 0.96 CYP2C19 (0.47) CYP2C19GABRR1CYP2D6CYP1A2ALOX15
Hydrochloric Acid SCHEMBL2385417 0.96 CYP2C19 (0.47) CYP2C19GABRR1CYP2D6CYP1A2ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113754871-B Biodegradable block copolyesters based on lactide- (cycloaliphatic-co-aromatic) -lactide 浙江恒逸石化研究院有限公司 2023-06-13 — — CN claimed
CN-113698585-B Biodegradable glycolide- (alicyclic-co-preparation method of aromatic) -glycolide block copolyesters 浙江恒逸石化研究院有限公司 2023-04-28 — — CN claimed
CN-113754871-A Biodegradable block copolyester based on lactide- (alicyclic-co-aromatic) -lactide 浙江恒澜科技有限公司 2021-12-07 — — CN claimed
CN-113698585-A Preparation method of biodegradable glycolide- (alicyclic-co-aromatic) -glycolide block copolyester 浙江恒澜科技有限公司 2021-11-26 — — CN claimed
EP-0543264-B1 Rewritable thermosensitive recording medium TOPPAN PRINTING CO LTD (JP) 1995-05-03 — — EP claimed
US-5278129-A Low molecular weight alicyclic dicarboxylic acid TOPPAN PRINTING CO., LTD. (JP) 1994-01-11 — — US claimed
EP-0543264-A1 Rewritable thermosensitive recording medium Toppan Printing Co., Ltd. (JP) 1993-05-26 — — EP claimed
WO-2025070456-A1 METHOD FOR PRODUCING HIGHLY-PURE BRANCHED POLYETHYLENE GLYCOL COMPOUND 日油株式会社 2025-04-03 — — WO disclosed
CN-113754871-B Biodegradable block copolyesters based on lactide- (cycloaliphatic-co-aromatic) -lactide 浙江恒逸石化研究院有限公司 2023-06-13 — — CN disclosed
US-11655360-B2 Gas-barrier resin composition and use thereof SHOWA DENKO K.K. (JP) 2023-05-23 — — US disclosed
CN-113698585-B Biodegradable glycolide- (alicyclic-co-preparation method of aromatic) -glycolide block copolyesters 浙江恒逸石化研究院有限公司 2023-04-28 — — CN disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 — — US disclosed
CN-110799600-B Gas barrier resin composition and use thereof 昭和电工株式会社 2022-06-21 — — CN disclosed
EP-1192203-A1 NOVEL LIQUID CRYSTALLINE POLYMERS Optatech Corporation (FI) 2002-04-03 — — EP disclosed
WO-2000066647-A1 NOVEL LIQUID CRYSTALLINE POLYMERS OPTATECH CORPORATION (FI) 2000-11-09 — — WO disclosed
US-6054448-A TREATMENT OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM. ELI LILLY AND COMPANY LIMITED (GB) 2000-04-25 — — US disclosed
EP-0837061-A1 Pharmaceutical acidic compounds ELI LILLY AND COMPANY LIMITED (GB) 1998-04-22 — — EP disclosed
EP-0543264-B1 Rewritable thermosensitive recording medium TOPPAN PRINTING CO LTD (JP) 1995-05-03 — — EP disclosed
US-5278129-A Low molecular weight alicyclic dicarboxylic acid TOPPAN PRINTING CO., LTD. (JP) 1994-01-11 — — US disclosed
EP-0543264-A1 Rewritable thermosensitive recording medium Toppan Printing Co., Ltd. (JP) 1993-05-26 — — EP disclosed
Send feedback